Exodus Point Capital Management, LP Biogen Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Biogen Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 62,915 shares of BIIB stock, worth $10.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

62,915

Previous 24,856 153.12%

Holding current value

$10.1 Million

Previous $5.76 Million 111.65%

% of portfolio

0.07%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $7.2 Million - $9.01 Million	38,059 Added 153.12%	62,915 $12.2 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $4.74 Million - $5.88 Million	24,856 New	24,856 $5.76 Million
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $38.6 Million - $43.5 Million	152,308 Added 267.9%	209,160 $53.8 Million
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $13.1 Million - $15.1 Million	-47,444 Reduced 45.49%	56,852 $16.2 Million
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $6.78 Million - $7.73 Million	26,437 Added 33.95%	104,296 $29 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $6.89 Million - $8.37 Million	27,298 Added 53.99%	77,859 $21.6 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $1.32 Million - $1.82 Million	-6,780 Reduced 11.82%	50,561 $13.5 Million
Q2 2022 Aug 19, 2022	BUY	$187.54 - $223.02 $4.65 Million - $5.53 Million	24,791 Added 76.16%	57,341 $11.7 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $3.41 Million - $4.29 Million	17,583 Added 117.48%	32,550 $6.86 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $247,879 - $318,561	1,107 Added 7.99%	14,967 $3.59 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $4.69 Million - $6.12 Million	-16,572 Reduced 54.46%	13,860 $3.92 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $7.11 Million - $11.4 Million	27,445 Added 918.81%	30,432 $10.5 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $1.5 Million - $1.76 Million	-6,176 Reduced 67.4%	2,987 $836,000
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.39 Million - $2.09 Million	5,872 Added 178.43%	9,163 $2.24 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $5.39 Million - $6.23 Million	-20,365 Reduced 86.09%	3,291 $934,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $6.12 Million - $8.1 Million	23,656 New	23,656 $6.33 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $246,804 - $313,074	-918 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $7.9 Million - $10.9 Million	-35,919 Reduced 97.51%	918 $272,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $8.01 Million - $8.98 Million	36,837 New	36,837 $8.58 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Biogen Inc. Transaction History